Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001161697-20-000517
Filing Date
2020-12-03
Accepted
2020-12-03 16:46:47
Documents
56
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR 09-30-2020 form_10-k.htm 10-K 600186
2 SUBSIDIARIES OF THE REGISTRANT ex_21.htm EX-21 974
3 RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION ex_31-1.htm EX-31 5655
4 SECTION 1350 CERTIFICATION ex_32-1.htm EX-32 3550
5 GRAPHIC angiosoma-logo.jpg GRAPHIC 12338
  Complete submission text file 0001161697-20-000517.txt   2985891

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE soan-20200930.xml EX-101.INS 407014
7 XBRL SCHEMA FILE soan-20200930.xsd EX-101.SCH 31430
8 XBRL CALCULATION FILE soan-20200930_cal.xml EX-101.CAL 42566
9 XBRL DEFINITION FILE soan-20200930_def.xml EX-101.DEF 151604
10 XBRL LABEL FILE soan-20200930_lab.xml EX-101.LAB 234952
11 XBRL PRESENTATION FILE soan-20200930_pre.xml EX-101.PRE 208062
Mailing Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042 832-781-8521
AngioSoma, Inc. (Filer) CIK: 0001502152 (see all company filings)

EIN.: 273480481 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-55072 | Film No.: 201367433
SIC: 2834 Pharmaceutical Preparations